M Koopmanschap
Overview
Explore the profile of M Koopmanschap including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
99
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Koopmanschap M
Diabetologia
. 2016 Dec;
45(Suppl 1):S21-S22.
PMID: 27942780
Aims/hypothesis: The Cost of Diabetes in Europe-Type II study is the first coordinated attempt to assess the total costs of Type II (non-insulin-dependent) diabetes mellitus in Europe. Although gaining a...
2.
Koopmanschap M
Diabetologia
. 2002 Jul;
45(7):S18-22.
PMID: 12136407
Aims/hypothesis: The Cost of Diabetes in Europe - Type II study is the first coordinated attempt to assess the total costs of Type II (non-insulin-dependent) diabetes mellitus in Europe. Although...
3.
Nuijten M, Engelfriet P, Duijn K, Bruijn G, Wierz D, Koopmanschap M
Pharmacoeconomics
. 2001 Dec;
19(10):1051-64.
PMID: 11735673
Objective: The objective of this study was to compare the total costs associated with the administration of two different tumour necrosis factor (TNF) strategies used in the treatment of rheumatoid...
4.
McDonnell J, Busschbach J, Kok E, van Exel J, Stolk E, Koopmanschap M, et al.
Eur Urol
. 2001 Mar;
39 Suppl 3:37-41.
PMID: 11275741
Given the ageing of western populations, the cost burden associated with the treatment of LUTS suggestive of BPO will increase substantially over the next few decades. Therefore, from the economic...
5.
Curran D, Aaronson N, Standaert B, Molenberghs G, Therasse P, Ramirez A, et al.
Eur J Cancer
. 2000 Apr;
36(7):834-44.
PMID: 10785587
Quality of Life (QL) is now included as an endpoint in many phase III cancer clinical trials. Numerous statistical techniques have been presented in the literature to analyse QL data...
6.
Meerding W, Polder J, Bonneux L, Koopmanschap M, van der Maas P
Lancet
. 1998 Jan;
351(9096):140-1.
PMID: 9439517
No abstract available.